These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34356183)

  • 1. Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
    Pozzi M; Avantaggiato P; Pastore V; Carnovale C; Clementi E; Strazzer S
    Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Use in Pediatric Patients Admitted to Rehabilitation For Severe Acquired Brain Injury: Analysis of the Associations With Rehabilitation Outcomes.
    Pozzi M; Galbiati S; Locatelli F; Carnovale C; Radice S; Strazzer S; Clementi E
    Paediatr Drugs; 2021 Jan; 23(1):75-86. PubMed ID: 33230677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine in children with nocturnal frontal-lobe epilepsy.
    Raju GP; Sarco DP; Poduri A; Riviello JJ; Bergin AM; Takeoka M
    Pediatr Neurol; 2007 Nov; 37(5):345-9. PubMed ID: 17950420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.
    Popova E; Leighton C; Bernabarre A; Bernardo M; Vieta E
    Expert Rev Neurother; 2007 Jun; 7(6):617-26. PubMed ID: 17563245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine, an antiepileptic agent.
    Kalis MM; Huff NA
    Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.
    Rocamora R; Peltola J; Assenza G; McMurray R; Villanueva V
    Seizure; 2020 Feb; 75():121-128. PubMed ID: 31981862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007963. PubMed ID: 23543558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy.
    Di Resta C; Ambrosi P; Curia G; Becchetti A
    Eur J Pharmacol; 2010 Sep; 643(1):13-20. PubMed ID: 20561518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.
    Hellewell JS
    J Affect Disord; 2002 Dec; 72 Suppl 1():S23-34. PubMed ID: 12589900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin.
    Sommer BR; Fenn HH; Ketter TA
    Expert Opin Drug Saf; 2007 Mar; 6(2):133-45. PubMed ID: 17367259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
    Friis ML; Kristensen O; Boas J; Dalby M; Deth SH; Gram L; Mikkelsen M; Pedersen B; Sabers A; Worm-Petersen J
    Acta Neurol Scand; 1993 Mar; 87(3):224-7. PubMed ID: 8475694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine: clinical experience with hospitalized psychiatric patients.
    Centorrino F; Albert MJ; Berry JM; Kelleher JP; Fellman V; Line G; Koukopoulos AE; Kidwell JE; Fogarty KV; Baldessarini RJ
    Bipolar Disord; 2003 Oct; 5(5):370-4. PubMed ID: 14525559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
    Dogra S; Beydoun S; Mazzola J; Hopwood M; Wan Y
    Eur J Pain; 2005 Oct; 9(5):543-54. PubMed ID: 16139183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: An observational study.
    Hur YJ
    Seizure; 2018 Aug; 60():123-126. PubMed ID: 29957441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial.
    Mattes JA
    J Clin Psychopharmacol; 2005 Dec; 25(6):575-9. PubMed ID: 16282841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.
    Dam M; Ekberg R; Løyning Y; Waltimo O; Jakobsen K
    Epilepsy Res; 1989; 3(1):70-6. PubMed ID: 2645120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxcarbazepine in the treatment of child psychiatric disorders: a retrospective chart review.
    Staller JA; Kunwar A; Simionescu M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):964-9. PubMed ID: 16379517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures.
    Donati F; Gobbi G; Campistol J; Rapatz G; Daehler M; Sturm Y; Aldenkamp AP;
    Seizure; 2007 Dec; 16(8):670-9. PubMed ID: 17574448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.